Fulgent Genetics (STU:7F0) Total Liabilities : €86.7 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Fulgent Genetics Total Liabilities?

Fulgent Genetics's Total Liabilities for the quarter that ended in Dec. 2024 was €86.7 Mil.

Fulgent Genetics's quarterly Total Liabilities declined from Jun. 2024 (€96.05 Mil) to Sep. 2024 (€89.08 Mil) and declined from Sep. 2024 (€89.08 Mil) to Dec. 2024 (€86.72 Mil).

Fulgent Genetics's annual Total Liabilities declined from Dec. 2022 (€109.67 Mil) to Dec. 2023 (€93.57 Mil) and declined from Dec. 2023 (€93.57 Mil) to Dec. 2024 (€86.72 Mil).

Fulgent Genetics Total Liabilities Historical Data

The historical data trend for Fulgent Genetics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Total Liabilities Chart

Fulgent Genetics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

107.74

99.86

109.67

93.57

86.72

Fulgent Genetics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															93.57	94.98	96.05	89.08	86.72

Fulgent Genetics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Fulgent Genetics's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	69.619	+	(6.315	+	4.702
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	6.083	+	0	+	0)
	=	86.7

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	1165.066	-	1078.347
	=	86.7

Fulgent Genetics's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	69.619	+	(6.315	+	4.702
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	6.083	+	0	+	0)
	=	86.7

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	1165.066	-	1078.347
	=	86.7

Fulgent Genetics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (STU:7F0) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

FLGT:USA FLGT:Mexico 7F0:Germany

Address

4399 Santa Anita Avenue, El Monte, CA, USA, 91731

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Fulgent Genetics Headlines

No Headlines